Lilly CEO argues for Japan trade deal.
Eli Lilly and Co., Indianapolis, Ind., CEO and Chairman Sidney Taurel recently made the case for a Japan-U.S. Economic Integration Agreement in a speech before the American Chamber of Commerce in Japan.
Taurel argued that Japan-U.S. integration could accelerate the pursuit of partnerships with third countries that make their individual companies and industries more competitive. He noted that Japan's pharmaceutical companies are some of the most innovative in the world, but suffer from clinical requirements and policies of the National Health Insurance system that fail to assure price premiums when new products come to market.
More info:-Eli Lilly and Co., www.lilly.com
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Eli Lilly and Co., Sidney Taurel|
|Publication:||R & D|
|Article Type:||Brief article|
|Date:||Sep 1, 2006|
|Previous Article:||China and Malaysia to develop biofuels.|
|Next Article:||World-class technologies for R&D and beyond: the 44th Annual R&D 100 Awards honor the world's best innovators and their innovations.|